Inventor
JACOBSON SVEN
US23 patents
⚠️ This page may combine multiple inventors who share the name “JACOBSON SVEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WOOLSEY PHARMACEUTICALS INC
8 patentsUS11642352B2May 9, 2023
Methods of treating wandering in Lewy dody dementia
WOOLSEY PHARMACEUTICALS INC3 citations71
US11311553B1Apr 26, 2022
Methods of treating 4-repeat tauopathies
WOOLSEY PHARMACEUTICALS INC5 citations71
US12329761B2Jun 17, 2025
Methods of using rho kinase inhibitors to treat alzheimer's disease
WOOLSEY PHARMACEUTICALS INC0 citations61
US12290522B2May 6, 2025
Method of treating amyotrophic lateral sclerosis
WOOLSEY PHARMACEUTICALS INC0 citations61
US11865119B2Jan 9, 2024
Methods of treating agitation and other dementia-associated behavioral symptoms
WOOLSEY PHARMACEUTICALS INC1 citations61
US11779588B2Oct 10, 2023
Method of treating amyotrophic lateral sclerosis
WOOLSEY PHARMACEUTICALS INC0 citations61
US11771704B1Oct 3, 2023
Methods of using rho kinase inhibitors to treat alzheimer's disease
WOOLSEY PHARMACEUTICALS INC1 citations61
US11666583B2Jun 6, 2023
Methods of treating cortical dementia associated wandering
WOOLSEY PHARMACEUTICALS INC1 citations61
CRITICAL CARE DIAGNOSTICS INC
6 patentsUS7998683B2Aug 16, 2011
Predicting mortality and detecting severe disease
CRITICAL CARE DIAGNOSTICS INC46 citations97
US9057733B2Jun 16, 2015
Predicting mortality and detecting severe disease
CRITICAL CARE DIAGNOSTICS INC15 citations92
US10303844B2May 28, 2019
Multimarker risk stratification
CRITICAL CARE DIAGNOSTICS INC6 citations83
US11016103B2May 25, 2021
Predicting mortality and detecting severe disease
CRITICAL CARE DIAGNOSTICS INC0 citations62
US10067146B2Sep 4, 2018
Predicting mortality and detecting severe disease
CRITICAL CARE DIAGNOSTICS INC1 citations62
US10741290B2Aug 11, 2020
Multimarker risk stratification
CRITICAL CARE DIAGNOSTICS INC1 citations61
SNIDER JAMES V
3 patentsBIOGEN CHESAPEAKE LLC
3 patentsUS10117834B2Nov 6, 2018
Formulations and methods for lyophilization and lyophilates provided thereby
BIOGEN CHESAPEAKE LLC4 citations83
US11304963B2Apr 19, 2022
Methods of medical treatment with SUR1-TRPM4 channel inhibitors
BIOGEN CHESAPEAKE LLC0 citations61
US10688111B2Jun 23, 2020
Liquid formulations of compounds active at sulfonylurea receptors
BIOGEN CHESAPEAKE LLC2 citations60